Comparison of weakness progression in <font color="blue">inclusion_1</font> <font color="blue">body_1</font> <font color="blue">myositis_1</font> during treatment with methotrexate or placebo . 
<br>
<br> <font color="blue">We_2</font> <font color="blue">investigated_2</font> <font color="blue">whether_2</font> <font color="blue">5_2</font> <font color="blue">to_2</font> <font color="blue">20_2</font> <font color="blue">mg_2</font> <font color="blue">per_2</font> <font color="blue">week_2</font> <font color="blue">oral_2</font> <font color="blue">methotrexate_2</font> <font color="blue">could_2</font> <font color="blue">slow_2</font> <font color="blue">down_2</font> <font color="blue">disease_2</font> <font color="blue">progression_2</font> <font color="blue">in_2</font> <font color="blue">44_6</font> <font color="blue">patients_6</font> <font color="blue">with_6</font> <font color="blue">inclusion_6</font> <font color="blue">body_6</font> <font color="blue">myositis_6</font> <font color="blue">in_4</font> <font color="blue">a_4</font> <font color="blue">randomized_4</font> <font color="blue">double_4</font> <font color="blue">-_4</font> <font color="blue">blind_4</font> <font color="blue">placebo_4</font> <font color="blue">-_4</font> <font color="blue">controlled_4</font> <font color="blue">study_4</font> <font color="blue">over_4</font> <font color="blue">48_4</font> <font color="blue">weeks_4</font> <font color="blue">._4</font> Mean change of quantitative muscle strength testing sum scores was the primary study outcome measure . Quantitative muscle strength testing sum scores declined in both treatment groups , -0.2% for methotrexate and -3.4% for placebo ( 95% confidence interval = -2.5% to + 9.1% for difference ) . There were also no differences in manual muscle testing sum scores , activity scale scores and patients ' own assessments after 48 weeks of treatment . Serum creatine kinase activity decreased significantly in the <font color="blue">methotrexate_1</font> <font color="blue">group_1</font> <font color="blue">._1</font> <font color="blue">We_1</font> <font color="blue">conclude_1</font> <font color="blue">that_1</font> <font color="blue">oral_1</font> <font color="blue">methotrexate_1</font> <font color="blue">did_1</font> <font color="blue">not_1</font> <font color="blue">slow_1</font> <font color="blue">down_1</font> <font color="blue">progression_1</font> <font color="blue">of_1</font> <font color="blue">muscle_1</font> <font color="blue">weakness_1</font> <font color="blue">but_1</font> <font color="blue">decreased_1</font> <font color="blue">serum_1</font> <font color="blue">creatine_1</font> <font color="blue">kinase_1</font> <font color="blue">activity_1</font> <font color="blue">._1</font>